Group One Trading
RYTM icon

Group One Trading’s Rhythm Pharmaceuticals RYTM Stock Holding History

Group One Trading’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,991
Closed -$239K – 7277
2024
Q2 		$205K Buy
4,991
+716
+17% +$28.6K ﹤0.01% 3364
2024
Q1 		$185K Buy
+4,275
New +$187K ﹤0.01% 3623
2022
Q1 		– Sell
-241
Closed -$2.12K – 8607
2021
Q4 		$2K Hold
241
– – ﹤0.01% 7903
2021
Q3 		$3K Sell
241
-733
-75% -$11.2K ﹤0.01% 7885
2021
Q2 		$19K Sell
974
-2,022
-67% -$42K ﹤0.01% 7224
2021
Q1 		$64K Buy
2,996
+2,590
+638% +$75.1K ﹤0.01% 6048
2020
Q4 		$12K Sell
406
-121
-23% -$3.08K ﹤0.01% 5735
2020
Q3 		$11K Buy
+527
New +$12.1K ﹤0.01% 5386

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Group One Trading's RYTM Position: Q3 2024 in Review

Group One Trading sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2024, closing a stake of 4,991 shares — an estimated $239K sold.

Group One Trading first reported a position in RYTM in Q3 2020 and held it in 8 quarters. The position peaked at $205K in Q2 2024. 176 funds tracked by Wall St. Rank hold RYTM as of Q3 2024.

  • Group One Trading reported no remaining Rhythm Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 4,991 Rhythm Pharmaceuticals shares in Q3 2024, an estimated $239K.
  • Group One Trading first reported a position in Rhythm Pharmaceuticals in Q3 2020 and held it in 8 quarters.
  • Group One Trading's Rhythm Pharmaceuticals position peaked at $205K in Q2 2024.
  • 176 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.